The markets traded mixed during the midday with the Dow gaining 29 points to 9965 as the Euro dropped to a four year low. Nasdaq lost 4 points to 2214.
On the upside
Medco Health Solutions (NYSE: MHS) launched its new Medco Pharmacy brand with an integrated marketing campaign.
Rising gold prices lifted shares of Barrick Gold (NYSE: ABX), Eldorado Gold (NYSE: EGO) and Iamgold (NYSE: IAG).
DirecTV (Nasdaq: DTV) launched its new Whole-Home DVR allowing customers to record and watch programs on any television in the home.
On the downside
Celldex (Nasdaq: CLDX) reported positive results from a midstage clinical trial of its skin cancer treatment CDX-011. The stock price fell after rival Bristol-Myers (NYSE: BMY) reported upbeat results for its advanced skin cancer treatment.
ArQule's (Nasdaq: ARQL) lung cancer drug failed a midstage clinical trial.
Keryx Biopharmaceuticals (Nasdaq: KERX) reported upbeat results from a Phase 1 study of KRX-0401 in treating recurrent pediatric solid tumors but the stock price fell.
In the broad market, advancing issues barely outpaced decliners by a slim margin on the NYSE while decliners edged out advancers by more than 5 to 3 on Nasdaq. The Russell 2000 which tracks small cap stocks slipped 2 points to 631.
